Download presentation
Presentation is loading. Please wait.
1
Bypass surgery versus endovascular interventions in severe or critical limb ischemia
Abd Moain Abu Dabrh, MBBCh, MS, Mark W. Steffen, MD, MPH, Noor Asi, MD, Chaitanya Undavalli, MBBS, Zhen Wang, PhD, Mohamed B. Elamin, MD, Michael S. Conte, MD, Mohammad Hassan Murad, MD, MPH Journal of Vascular Surgery Volume 63, Issue 1, Pages e11 (January 2016) DOI: /j.jvs Copyright © 2016 Society for Vascular Surgery Terms and Conditions
2
Fig 1 Flowchart shows the selection process of eligible studies. CLI, Critical limb ischemia; RCTs, randomized clinical trials. Journal of Vascular Surgery , e11DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
3
Fig 2 Mortality in patients receiving bypass surgery vs endovascular treatment based on study design. CI, Confidence interval; OR, odds ratio; RCT, randomized clinical trial. Journal of Vascular Surgery , e11DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
4
Fig 3 Limb loss (by number of patients) in patients receiving bypass surgery vs endovascular treatment based on study design. CI, Confidence interval; OR, odds ratio; RCT, randomized clinical trial. Journal of Vascular Surgery , e11DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
5
Fig 4 Primary patency in patients receiving bypass surgery vs endovascular treatment. CI, Confidence interval; OR, odds ratio; RCT, randomized clinical trial. Journal of Vascular Surgery , e11DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
6
Supplementary Fig 1 (online only)
Mortality in patients who received bypass surgery vs endovascular treatment based on use of diagnostic criteria [mixed (0) vs hemodynamic (1)]. CI, Confidence interval; OR, odds ratio. Journal of Vascular Surgery , e11DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
7
Supplementary Fig 2 (online only)
Mortality in patients who received bypass surgery vs endovascular treatment by year of follow-up. CI, Confidence interval; OR, odds ratio. Journal of Vascular Surgery , e11DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
8
Supplementary Fig 3 (online only)
Limb loss (by number of patients) in patients who received bypass surgery vs endovascular treatment based on follow-up year. CI, Confidence interval; OR, odds ratio. Journal of Vascular Surgery , e11DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
9
Supplementary Fig 4 (online only)
Limb loss (by number of patients) in patients who received bypass surgery vs endovascular treatment based on use of criteria [mixed (0) vs hemodynamic (1)]. CI, Confidence interval; OR, odds ratio. Journal of Vascular Surgery , e11DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
10
Supplementary Fig 5 (online only)
Limb loss (by number of limbs) in patients who received bypass surgery vs endovascular treatment. CI, Confidence interval; OR, odds ratio. Journal of Vascular Surgery , e11DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
11
Supplementary Fig 6 (online only)
Primary patency in patients who received bypass surgery vs endovascular treatment by year of follow-up. CI, Confidence interval; OR, odds ratio. Journal of Vascular Surgery , e11DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
12
Supplementary Fig 7 (online only)
Assisted primary patency in patients who received bypass surgery vs endovascular treatment. CI, Confidence interval; OR, odds ratio. Journal of Vascular Surgery , e11DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
13
Supplementary Fig 8 (online only)
Secondary patency in patients who received bypass surgery vs endovascular treatment. CI, Confidence interval; OR, odds ratio. Journal of Vascular Surgery , e11DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.